首页> 外文期刊>Complementary therapies in clinical practice >A randomized controlled trial of electroacupuncture at body acupoints and Fenglong for regulating serum lipids in dyslipidemic patients in Thailand
【24h】

A randomized controlled trial of electroacupuncture at body acupoints and Fenglong for regulating serum lipids in dyslipidemic patients in Thailand

机译:在泰国进行血脂异常患者体内电针和风龙调节血脂的随机对照试验

获取原文
获取原文并翻译 | 示例
           

摘要

The primary objective of this randomized, controlled, open-label study was to compare the efficacy of body acupuncture and Fenglong method in controlling serum lipids in patients with dyslipidemia in Thailand. Patients were randomized into two treatment groups (body acupuncture and Fenglong) and a control group. By the end of intervention period, serum lipid level in both treatment groups was significantly lower than its baseline value while in the control group serum lipid levels significantly increased during the same period. At follow-up visit, total cholesterol and LDL cholesterol were significantly lower in both treatment groups when compared to the control group. The effect of both acupuncture interventions was seen in both obese and non-obese patients. In conclusion, body acupuncture and Fenglong method have a positive impact on the regulation of serum lipids that is sustained after the treatment regardless of patient's baseline weight.
机译:这项随机,对照,开放标签研究的主要目的是比较泰国针灸和丰隆法在控制血脂异常患者中控制血脂的功效。将患者随机分为两个治疗组(体针和风龙)和对照组。到干预期结束时,两个治疗组的血脂水平均显着低于其基线值,而对照组的血脂水平在同期显着增加。随访时,与对照组相比,两个治疗组的总胆固醇和LDL胆固醇均显着降低。在肥胖和非肥胖患者中都可以看到针刺干预的效果。总之,无论患者的基线体重如何,全身针刺和风龙法对治疗后维持的血脂调节均具有积极影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号